Pharmacy Disclosure Log 2023

  1. AML and CLL Response 7920
  2. Antibiotic Administration Set Line Flushing Response 8129
  3. Anti-Diabetic Products for the Formulary Response 7953
  4. Asthma Treatment Response 8046
  5. Biologic and Biosimilar Products Response 7883
  6. Biologic and Biosimilar Products Response 8090
  7. Biologic Medicines in Dermatology Response 8093
  8. Biologic Medicines in Dermatology Response 7889
  9. Biologic Medicines in Gastroenterology Response 8136
  10. Blood Tests in Maternity Services Response 8202
  11. Breast Cancer Response 8165
  12. Chitin Chitosan Response 8186
  13. Dabrafenib and Trametinib in cancer treatment Response 8031
  14. Dermatology and Respiratory Medicine Response 8054
  15. Dermatological Conditions Response 8055
  16. Early Access to Medicines Scheme (EAMS) Response 8051
  17. Formularies and Committees Response 8120
  18. Gastroenterology Response 7930
  19. HIV & PrEP Response 8183
  20. Immunoglobulin Treatments Response 8017
  21. Immunoglobulin Treatments Response 8017
  22. Incidence and Treatment of Urothelial and Colorectal Cancer Response 8218
  23. Intraosseous Blood Samples Response 8098
  24. Local Formulary Response 7898
  25. Migraine Response 8147
  26. Multiple Myeloma Response 8184
  27. NHS Healthcare Treatment Response 8131
  28. NHS Drug Expiry Costs Response 8016
  29. Non-Small Cell Lung Cancer Response 8217
  30. Oesophageal and Gastric Cancer Response 8210
  31. Non-Small Cell Lung Cancer Response 7952
  32. Oesophageal and Gastric Cancer Response 7991
  33. Ovarian Cancer Response 8106
  34. Patients Receiving Treatment Response 8212
  35. Renal Cell Carcinoma Response 8161
  36. Renal Cell Carcinoma Response 8161 Attachment
  37. Renal Cell Carcinoma Response 7957
  38. Renal Cell Carcinoma Response 7957 - Attachment
  39. Self-Administration of Medication Response 8105
  40. Spinal Muscular Atrophy Response 7886
  41. Spinal Muscular Atrophy Response 7886 - Attachment
  42. Treatment of Breast Cancer Response 7965
  43. Treatment for Myelofibrosis Response 7986
  44. Treatment of Myelofibrosis Response 7986 - Attachment
  45. Treatment of Melanoma Response 8032
  46. Treatment of Urothelial and Colorectal Cancer Response 7998

Last Modified: 3:29pm 14/08/2023

Pharmacy Disclosure Log 2023In this section